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Abstract
Background: The human liver fluke, Opisthorchis viverrini, is designated as a group 1 carcinogen, and is the major risk factor
for cholangiocarcinoma in endemic countries throughout Southeast Asia. Proteins in the excretory-secretory products and
tegumental surface membranes of the fluke have been proposed to play pivotal roles in parasite survival in the host, and
subsequent pathogenesis. These macromolecules are therefore valid targets for the development of vaccines and new
drugs to control the infection. Tetraspanins (TSP) are prominent components of the tegument of blood flukes where they
are essential for tegument formation, are directly exposed to the immune system, and are major targets for a
schistosomiasis vaccine. We propose that similar molecules in the surface membranes of O. viverrini are integral to
tegument biogenesis and will be efficacious vaccine antigens.
Methodology/Principal Findings: The cDNA sequence encoding O. viverrini tetraspanin-1 (Ov-TSP-1) was identified and
cloned. The Ov-tsp-1gene was isolated from a cDNA library. Ov-tsp-1 mRNA was expressed most highly in metacercariae and
eggs, and to a lesser extent in juvenile and adult worms. Immunolocalization with adult flukes confirmed that Ov-TSP-1 was
expressed in the tegument and eggs in utero. Western blot analysis of rOv-TSP-1 probed with sera from O. viverrini-infected
humans and hamsters indicated that both hosts raise antibody responses against the native TSP. Using RNA interference we
silenced the expression level of Ov-tsp-1 mRNA in adult flukes by up to 72% by 10 days after delivery of dsRNA.
Ultrastructural morphology of adult worms treated with Ov-tsp-1 dsRNA displayed a distinctly vacuolated and thinner
tegument compared with controls.
Conclusions/Significance: This is the first report of a tetraspanin from the tegument of a liver fluke. Our data imply that
tetraspanins play important structural roles in the development of the tegument in the adult fluke. Potential uses of O.
viverrini tetraspanins as novel interventions are discussed.
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Introduction
The human liver fluke Opisthorchis viverrini has been classified by
the World Health Organization’s International Agency for
Research on Cancer as a Group 1 carcinogen [1]. Approximately
10 million people in Southeast Asia are infected with this neglected
parasite [2], and a further 15–20 million are infected throughout
Asia with the closely related Clonorchis sinensis [3]. Treatment with
praziquantel is effective in eliminating current infections, but rapid
re-infection occurs and can be accompanied by severe pathology
[4,5]. The pathogenesis, control and re-emergence of O. viverrini
infection, particularly in Thailand, and the association of O.
viverrini infection and bile duct cancer have been reviewed recently
[6,7,8].
New interventions for long-term prevention, such as a vaccine,
are urgently needed. It has been proposed that molecules in the
excretory-secretory (ES) products and outer epithelial surfaces of
this fluke play key roles in the pathogenesis of opisthorchiasis and
mediate the fluke’s parasitic existence [9,10]. We recently
characterized the tegument proteome of adult O. viverrini and
identified those proteins exposed on the surface of live worms
using a selective biotinylation approach [11]. Of the transmem-
brane proteins identified, one shared sequence identity with the
tetraspanin family of transmembrane proteins. Tetraspanins
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contain 4 transmembrane domains and are frequently expressed at
the cell surface in association with each other and with other
molecules, such as integrins, where they function to regulate cell
adhesion, migration, proliferation, and differentiation [12,13].
Tetraspanins have also been shown to act as receptors for viruses,
most notably CD81 binding to hepatitis C [14].
Tetraspanins are prominent on the surface of the intra-
mammalian stages of the human blood fluke, Schistosoma mansoni.
Sm-TSP-2 is a tetraspanin from the tegument of S. mansoni [15,16]
that is essential for proper tegument formation, and silencing of
the Sm-tsp-2 gene proved lethal for schistosomula in vivo [17].
Indeed, the S. mansoni genome contains a large family of
tetraspanin-encoding genes that have diverse expression profiles
[18], and one of the most highly upregulated genes in developing
schistosomula encodes a tetraspanin on the tegument surface [19].
The tegument of O. viverrini metacercariae, juvenile and adult
flukes is exposed to the mammalian host tissues; indeed the
tegument of the adult fluke forms an intimate contact with the host
biliary epithelium [20], resulting in chronic cell proliferation,
immunopathology and ultimately tumorigenesis [21,22]. In
addition, molecules in the tegument membranes are a major
target for the development of new drugs and vaccines against the
parasite. The transcriptome [23,24] and secreted proteome [11] of
O. viverrini have been characterized, revealing tetraspanins as a
major component of the tegument membrane. The tegument in
particular plays a crucial role in survival of parasitic flukes and is
therefore considered as a target for vaccine development in
schistosomiasis [15]. Indeed, Sm-TSP-2 from S. mansoni is entering
Phase I clinical trials [25], and a tetraspanin from the zoonotic
Schistosoma japonicum (Sj23) is being considered as a vaccine
targeting the buffalo reservoir host in an attempt to interrupt
transmission to humans [26]. TSPs have recently proven to be
efficacious vaccine antigens against cestode parasites [27],
highlighting their efficacy in multiple classes of platyhelminths.
While less information is available for tegument protein vaccines
from liver flukes, efficacy with tegument extracts has been reported
for Fasciola hepatica [28] and with a recombinant tegument protein
from C. sinensis [29].
Here, for the first time, we describe the cloning and
characterization of a liver fluke tetraspanin, Ov-tsp-1, and locate
its site of expression to the tegument of adult flukes. Suppression of
Ov-tsp-1 in adult flukes impacts on proper tegument formation and
results in increased vacuolation, implying that this protein is
essential for fluke development and survival and is therefore
worthy of consideration as a vaccine and/or drug target.
Materials and Methods
Opisthorchis viverrini
Metacercariae of O. viverrini were collected from infected fishes
obtained from reservoirs in Khon Kaen province, Thailand. Fishes
were digested with pepsin as described [23]. Syrian golden
hamsters (Mesocricetus auratas) were infected with 50–100 metacer-
cariae each via an intragastric tube. Hamsters were maintained at
the animal facility, Faculty of Medicine, Khon Kaen University
and protocols used for animal experimentation were approved by
the Animal Ethics Committee of Khon Kaen University based on
the Ethics of Animal Experimentation of the National Research
Council of Thailand. Juvenile flukes (2 weeks old) with incom-
pletely developed reproductive organs [30] and adult flukes (6
weeks old) were harvested from gall bladders and bile ducts of
hamsters. To collect O. viverrini eggs, adult worms were cultured in
RPMI supplemented with 16antibiotics (streptomycin/penicillin,
100 mg/ml) at 37uC under 5% CO2 in air. After 18 h incubation,
culture medium was collected and centrifuged at 5,000 rpm for
10 min to collect the eggs. Eggs were stored at 270uC until
required [31].
Cloning of Ov-tsp-1 cDNA
The cDNA encoding the open reading frame (ORF) of Ov-tsp-1
was obtained by PCR from an adult worm cDNA library [23].
Oligonucleotide primers for PCR to amplify the complete ORF
were designed based on expressed sequence tags (ESTs) [23,24].
The primers used were Ov-TSP1F (59-ATGAGATGATGG
GTTGTGTCCAATGC-39) and Ov-TSP1R (59-AGTCACT-
TAAGTTGCTATGGCATAGTCC-39). PCR reactions were
conducted as follows: 100 ng of O. viverrini cDNA library as
template, 0.2 mM dNTP, 1.5 mM MgCl2 performed with 1 unit
Taq polymerase (Invitrogen, Germany) with 35 cycles of denatur-
ation at 95uC for 1 min, annealing at 60uC for 1 min, extension at
72uC for 2 min and a final extension at 72uC for 10 min. PCR
products were identified by agarose gel electrophoresis and
purified by gel extraction with a commercial gel extraction kit
(Fermentas, EU). PCR products were sequenced before ligation
into the pGEM T Easy vector (Promega, USA), and this construct
was used to transform E. coli JM109 competent cells (Promega).
Sequences were subjected to BLAST searching against the
GenBank database. Recombinant clones were screened for
ampicillin resistance and blue/white selection, and sequence
inserts confirmed by PCR amplification using oligonucleotide
primers corresponding to the multiple cloning site promoter
sequences, T7 and SP6. White colonies were selected, and insert
sequences determined using the BigDye terminator method (1st
BASE, Singapore).
Sequence analysis
DNA sequences were evaluated using BioEdit V7.0.5 [32]. The
edited sequences were translated to protein using web based
translation software at http://bio.lundberg.gu.se/edu/translat.
html and compared to related sequences using the basic local
alignment search tool (BLAST) at http://blast.ncbi.nlm.nih.gov/
[33]. Signal peptide analysis was conducted with the SignalP 3.0
Author Summary
Liver fluke infection is a fish borne disease that afflicts
millions of residents in Thailand and Laos. Infection results
from eating undercooked freshwater fish contaminated
with larvae of the worm Opisthorchis viverrini. Infection can
lead to cancer of the bile ducts (cholangiocarcinoma).
Indeed, O. viverrini is designated as a Group 1 carcinogen
by the World Health Organization, i.e. a definitive cause for
cancer. Proteins produced at the surface and/or released
from this parasite play pivotal roles in maintaining the
infection and disease. These proteins are valid targets for
development of vaccines and new drugs. Tetraspanins are
prominent in the tegument (the surface covering) of
parasites closely related to O. viverrini where they are
exposed to immune responses. Similar molecules on the
surface of O. viverrini may be vital for the parasite’s survival
and may make effective vaccines. Here the gene coding for
O. viverrini tetraspanin-1 (Ov-TSP-1) was investigated. We
used electron microscopy to show that Ov-TSP-1 is
expressed in the tegument. We then silenced expression
of the gene encoding Ov-TSP-1 and showed that this
resulted in malformation of the tegument, highlighting the
importance of this molecule for parasite development and
its potential as a vaccine target.
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Server at http://www.cbs.dtu.dk/services/SignalP/. Multiple se-
quence alignments were compiled using ClustalW in the BioEdit
program. Transmembrane regions were predicted using the TMpred
server at http://www.ch.embnet.org/software/TMPRED_form.html.
Phylogenetic analysis
Phylogenetic relationships among Ov-TSP-1 and TSPs from a
range of organisms was constructed based on amino acid
sequences. ORFs were aligned using ClustalW [34]. A phyloge-
netic tree was constructed with p-distance matrix using the
neighbor-joining method [35] with 1,000 bootstrap samplings in
the MEGA software package version 4.0.2 [36,37].
Cloning and recombinant protein production of the large
extracellular loop region of Ov-TSP-1
The nucleotide sequence corresponding to the large extracel-
lular loop (LEL) region of Ov-TSP-1 (amino acid residues 106 to
202) was identified using TMpred and amplified by PCR with the
forward primers TSP1_EC2F_pET, 59-AGCCATATGGGC-
TATGTGTTCCGGGAG and the reverse primer TSP1_EC2R_-
pET, 59-AGCGGATCCCTACTTGTCCTTGAAGAATCG
that incorporated an Nde I site at the 59 end and a Bam HI site
at the 39 end (underlined) to ensure in-frame fusion with the
vector-derived 66His epitope at the N-terminus of the pET-15b
expression vector (Novagen, USA). PCR products were sub-cloned
into pGEM-T. Recombinant plasmids were then digested with Nde
I and Bam HI, and Nde I/Bam HI fragments cloned into pET-15b
to produce plasmid pLEL-Ov-TSP-1; the identity and in-frame
fusion to the 66His tag of the insert was confirmed by sequencing.
BL21DE3 strain E. coli (Novagen) was transformed with pLEL-
Ov-TSP-1. Transformed bacteria were induced with 1 mM IPTG
in LB medium for 3 hr at 37uC on a shaking platform to produce
recombinant LEL-Ov-TSP-1. Recombinant LEL-Ov-TSP-1 was
purified by affinity chromatography (HisNBind Resin, Novagen)
under denaturing condition with 6M urea. The protein was
refolded by dialysis against PBS and analyzed by Coomassie
stained SDS-PAGE.
Synthesis of double-stranded RNAs (dsRNAs)
dsRNAs derived from either Ov-tsp-1 or firefly luciferase (LUC)
were prepared from plasmid DNA using a MEGAscript RNAi Kit
(Ambion), following the manufacturer’s instructions. dsRNA target-
ing Ov-tsp-1 was amplified from a plasmid (above) using primers
flanked with T7 RNA polymerase promoter sequence (underlined) at
the 59 ends. The Ov-tsp-1 dsRNA of 519 bp (residues 133–651 of the
transcript, GenBank accession JQ678706) was generated using
primers ds-TSP1_T7-F, 59 TAATACGACTCACTATAGGGG
CGTCCGGACACTATG and ds-TSP1_T7-R, 59 TAATA-
CGACTCACTATAGGGCTCGAAGGCGGCAATTGAC. The
PCR conditions were 35 cycles of denaturation at 95uC for 30 sec,
annealing at 60uC for 30 sec, extension at 72uC for 1 min, final
extension at 72uC for 10 min. An irrelevant negative control, luciferase
dsRNA derived from pGL3-basic (www.promega.com), was ampli-
fied using primers ds-LUC_T7-F59 TAATACGACTCACTA-
TAGGG TGCGCCCGCGAACGACATTTA and ds-LUC_T7-
R59 TAATACGACTCACTATAGGG GCAACCGCTTCCCC-
GACTTCCTTA [38]. Integrities of the dsRNAs were assessed on a
1% agarose gel and concentrations determined by spectrophotometer
(NanoVue, GE Healthcare, USA).
Delivery of dsRNA by electroporation
Adult worms were washed prior to electroporation [31]. Thirty
worms in each group (4 groups) were resuspended in 100 ml of
culture medium (16RPMI-1640, 16 antibiotic/antimycotic, 1%
glucose, 1 mM E 64) supplemented with 50 mg Ov-tsp-1 or luc
dsRNAs in 4 mm gap cuvettes (Bio-Rad, Hercules, CA, USA) and
exposed to single square wave electroporation at 125 V with
20 ms duration (Electroporator Gene Pulser Xcell, Bio-Rad). After
pulsing, worms were maintained in culture medium supplemented
with 2 mg dsRNA at 37uC under 5% CO2 in air. Worms were
soaked in 2 mg dsRNA for 16 days with changes of media
containing dsRNA every second day. Parasites were harvested at
days 1, 3, 6, 10 and 16. Moreover, dsRNA-treated adults parasite
were sampled on days 1, 3 and 6 and fixed in 3% glutaraldehyde
in 0.1 M phosphate buffer at pH 7.4 for transmission electron
microscopy.
RNA extraction and real time quantitative RT-PCR
Total RNA of adult and juvenile flukes, metacercariae and eggs
of O. viverrini was extracted in TRIZOL (Invitrogen, USA).
Concentrations of RNA were determined with a spectrophotom-
eter. Real time qRT-PCR (qPCR) was performed to detect
expression of Ov-tsp-1 O. viverrini. First strand cDNA was
synthesized from 1 mg of DNase treated RNA using a cDNA
synthesis kit (Fermentas). The Ov-tsp-1 specific primers spanned nt
1- 192. The primers were TSP1_EXF 59-AT-
GATGGGTTGTGTCCAATGC-39 and TSP1_EXR 59-AC-
CGCCGACTCCCATGAGAGC-39. The SYBR Green reagent
was used for qPCR with a Mx3005P Real-time-PCR System
(STRATAGENE, USA). SYBR Green reactions consisted of
6.25 ml of 26Brilliant SYBR Green QPCR Master Mix
(STRATAGENE), 0.75 ml (10 mM) of forward primer and reverse
primer, 0.1875 ml of reference Dye (ROX; 1:200), 100 ng of first-
stand cDNA and sterile water to a final volume of 12.5 ml.
Duplicate reactions were carried out, as follows: initiation pre-heat
for one cycle at 95uC for 10 min followed by 40 cycles of
denaturation at 95uC for 30 sec, annealing at 55uC for 30 sec and
extension at 72uC for 1 min. The expression of candidate mRNAs
was measured using actin mRNA as a constitutively expressed
control. To evaluate transcript levels in adult worms exposed to
dsRNAs, total RNA was extracted from individual worms using
TRIZOL reagent and contaminating genomic DNA was removed
by DNase I. qPCR was performed using an ABI7500 thermal
cycler using the SYBR Green assay; triplicate samples were
included in each group. PCR reactions consisted of 12.5 ml of
SYBR Green Master Mix (TAKARA Perfect Real-time Kit),
0.5 ml (10 mM) of forward primer and reverse primers, 0.5 ml of
reference Dye (ROX), 1 ml (equivalent to 50 ng of total RNA) of
first- stand cDNA and water to a final volume of 25 ml. PCR
cycling conditions were initiation pre-heat for one cycle at 95uC
for 10 minutes followed by 40 cycles of denaturation at 95uC for
30 seconds, annealing at 55uC for 30 seconds and extension at
72uC for 45 seconds. Expression levels of the Ov-tsp-1 and actin
mRNAs (OvAE1657, GenBank EL620339.1) [23] were deter-
mined. The mRNA expression level of Ov-tsp-1 (or LUC) was
normalized with actin mRNA and presented as the unit value of
22DDCt where DDCt=DCt (treated worms) 2DCt (non-treated
worms) [39]. Data are presented as the mean 6 standard error.
Differences between groups were assessed using Student’s t-test
(GraphPad Prism Software, www.graphpad.com); p#0.05.was
considered statistically significant.
Production of antiserum
Anti-rOv-TSP-1 serum was produced in BALB/c mice. For the
first immunization, purified recombinant Ov-TSP-1 (100 mg per
mouse per immunization) was emulsified in Freund’s com-
plete adjuvant (Sigma-Aldrich, St. Louis, MO, USA) and
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subcutaneously injected. Mice were boosted twice at two weekly
intervals using the same quantity of protein formulated with
Freund’s incomplete adjuvant (Sigma-Aldrich). Blood was col-
lected from each mouse before immunization and again at two
weeks after the final immunization.
Western blot analysis
An immunoblot assay was performed to identify anti-Ov-TSP-1
serum antibodies in naturally infected humans and experimentally
infected golden Syrian hamsters determined to be positive for O.
viverrini infection by fecal microscopy. Samples were from a pre-
existing collection of de-identified sera (the protocol had been
approved by The Khon Kaen University Ethics Committee for
Human Research based on the declaration of Helsinki and the
ICH Good Clinical Practice Guideline). Recombinant Ov-TSP-1
was resuspended in denaturing buffer, boiled for 5 min, and run
on a 17% SDS-PAGE gel. Proteins were transblotted onto
nitrocellulose membrane (Mini Trans-Blot Cell, Bio-Rad). The
membrane was cut into strips, each strip containing 6 mg of
recombinant Ov-TSP-1. The strips were washed with PBST (16
PBS + 0.01% Tween-20) for 5 min then blocked for 1 h with
blocking buffer (5% skimmed milk in PBST). Strips were
incubated with sera from patients and hamsters. Non-infected
hamsters served as negative controls. Sera from mice immunized
with recombinant Ov-TSP-1 were used as positive controls. All
sera were diluted at 1:50 in antibody buffer (2% skimmed milk in
PBST) and incubated overnight at 4uC with shaking. Strips were
washed twice with PBST for 10 min followed by incubation for
2 h with HRP-goat anti-human IgG, HRP-goat anti-hamster IgG
and HRP-goat anti-mouse IgG (diluted 1:1,000 in antibody
buffer). The strips were washed again with PBST twice for 10 min
and color reactions were detected by adding 3, 39-diaminobenzi-
dine (DAB) substrate.
Immunohistochemistry
Sections containing adult O. viverrini were de-paraffinized using
xylene then rehydrated in an ethanol series, 100%, 90%, 80% and
70% ethanol, 5 min each. Sections were immersed in citrate buffer
(pH 6) and autoclaved for 10 min for antigen unmasking, followed
by blocking with 3% H2O2 in methanol. Thereafter they were
incubated overnight at 4uC in mouse anti-Ov-TSP-1 sera diluted
1:200 in PBS. Sections were probed with goat-anti-mouse IgG-
HRP (Invitrogen, USA) diluted 1:1,000 dilution in PBS. Perox-
idase reaction products were visualized with 3,39-diaminobenzi-
dine (DAB) (Sigma-Aldrich). Counterstaining was performed with
Mayer’s hematoxylin for 5 min. A positive signal was indicated by
a reddish-brown color under light microscopy.
Transmission electron microscopy (TEM)
Adult worms, electroporated with 2 mg/ml of Ov-tsp-1 or
luciferase dsRNAs and cultured for 7 days at 37uC under 5%
CO2 atmosphere, were washed then fixed in 3% glutaraldehyde in
0.1 M phosphate, pH 7.4, followed by fixation in potassium
ferricyanide-reduced osmium tetroxide. Fixed worms were dehy-
drated in acetone and embedded in Epon Resin (ProSciTech,
Australia). Ultrathin sections were mounted onto copper grids,
contrasted in uranyl acetate and lead citrate and examined using a
JEM 1011 transmission electron microscope (Jeol) operated at
80 kV and equipped with a digital camera.
GenBank accession number
The sequence of the transcript coding for O. viverrini tetraspanin-
1 has been assigned GenBank accession number JQ678706.
Results
General characteristics of Ov-tsp-1
A full-length cDNA sequence encoding the first CD9-like
tetraspanin from a liver fluke is described, and was designated, Ov-
tsp-1. The sequence was assigned GenBank accession number
JQ678706. The open reading frame consists of 744 base pairs
encoding putative protein of 247 amino acids. Ov-TSP-1 contains
four transmembrane domains, a short extracellular loop (EC1 – 24
amino acids), a very short intracellular loop (4 amino acids), and a
large extracellular loop (LEL) or extracellular loop 2 (EC2 – 97
amino acids), flanked by a relatively short N-terminal and C-
terminal cytoplasmic tails (9, 25 amino acids) (Figure 1A). The
LEL is subdivided into a constant region (containing a helices A, B
and E), and a variable region, containing various protein–protein
interaction sites (Figure 1A and 1B). A secretory signal peptide was
predicted from the deduced amino acid sequence with a putative
cleavage site located between amino acids 30 and 31 (GFS-VY).
Ov-TSP-1 showed the conserved characteristics of the TSP family,
notably the signature cysteine–cysteine-glycine (CCG) motif in the
LEL, which is the location for the formation of three disulfide
bonds within the LEL and influences interactions with other
molecules (Figure 1). The deduced amino acid sequence compar-
ison between Ov-TSP-1 and other tetraspanins from various
organisms in GenBank protein databases showed that Ov-TSP-1
shares 97% identity with a TSP of its close relative, Clonorchis
sinensis (GAA49954.1) calculated from the alignment over 229
amino acid (amino acid position 19–247 of Ov-TSP-1 to 87–315 of
C. sinensis), and 74% identity with Sm-TSP-1 of Schistosoma mansoni
(XP_002580456.1) (Figure 1). Phylogenetic analysis of Ov-TSP-1
and related TSPs was drawn based on amino acid sequences
presences in 2 clades; CD and CD63 families. Ov-TSP-1 is in the
largest cluster of the tetraspanin family, the CD family [40]. It is
grouped together with C. sinensis (GAA49954.1) while S. mansoni
and S. japonicum CD9-like proteins are classified in a sister group
(Figure 2).
Ov-tsp-1 is expressed throughout the developmental
cycle of O. viverrini
The expression profile of Ov-tsp-1 in the different developmental
stages of O. viverrini was examined by qPCR using RNAs isolated
from adult flukes, two-week old juvenile flukes, metacercariae and
eggs. Ov-tsp-1 is expressed in all stages; expression was highest in
metacercariae followed by two-week old juveniles, adults and eggs
in descending order (Figure 3). Expression levels of the actin gene
of O. viverrini, Ov-actin, employed here as an internal control,
appeared to be similar and unchanged among developmental
stages.
Ov-TSP-1 is expressed in the tegument of adult O.
viverrini
The recombinant LEL domain of Ov-TSP-1 (residues 106–202;
rOv-TSP-1) produced in E. coli was predominantly found in the
insoluble pellet, and required 6 M urea to solubilize. The
recombinant protein was purified using nickel chelate affinity
chromatography under denaturing conditions, and desalted using
Ultra-15 Centrifugal Filter cartridges. SDS-PAGE and immuno-
blot analysis of the recombinant protein showed migration of the
expected molecular mass (,14 kDa). Purified and desalted rOv-
TSP-1 was used to immunize mice. Anti-Ov-TSP-1 serum
localized Ov-TSP-1 to the tegument of adult worms in the liver
of hamsters infected with O. viverrini. Pre-immunization serum did
not stain any O. viverrini tissues (Figure 4). Immunoblot analysis
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showed that sera from humans and hamsters infected with O.
viverrini both reacted with rOv-TSP-1 (Figure 5).
dsRNA mediated knockdown of Ov-tsp-1 expression
dsRNA of Ov-tsp-1 was introduced into adult worms by square
wave electroporation followed by soaking to mediate knockdown
of Ov-tsp-1 via the RNAi pathway. This RNAi procedure knocked
down expression of Ov-tsp-1 by 67% (p=0.06), 72% (p=0.01) and
55% (p=0.02) on days 6, 10 and 16 in vitro, respectively, compared
to the negative control group that received luciferase dsRNA
(Figure 6). The cultured flukes were visually monitored for viability
on a daily basis; no differences were evident among treatment
groups (not shown).
Suppression of Ov-tsp-1 mRNA results in malformation of
the tegument
To investigate the effect of silencing Ov-tsp-1 expression on the
formation of the O. viverrini tegument, adult flukes that had been
exposed to Ov-tsp-1 dsRNA in vitro were visualized by TEM. Ov-tsp-
1 dsRNA-treated worms cultured for one to three days displayed
Figure 1. Sequence and structure of Ov-TSP-1, a tetraspanin from Opisthorchis viverrini. Panel A: Schematic illustration of the structural
design of Ov-TSP-1. Panel B: Multiple sequence alignment of the deduced amino acid sequence of Ov-TSP-1 with other members of the tetraspanin
superfamily. Large extracellular loops are enclosed in boxes. Identical residues of sequences are shown in black boxes, conserved substitutions in gray
boxes.
doi:10.1371/journal.pntd.0001939.g001
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an anatomically dissimilar tegument structure to that from control
worms exposed to luciferase dsRNA (Figure 7). The tegument of Ov-
tsp-1 dsRNA treated worms (Figure 7C, E and F) was more highly
vacuolated than firefly luciferease dsRNA and non dsRNA controls
(Figure 7B, A and D), with extensive and enlarged vacuoles
throughout the surface layer.
Figure 2. Phylogenetic analysis of tetraspanins from Opisthorchis viverrini and homologs from related superfamilies. O. viverrini
tetraspanins can be grouped within extant two families, the CD family and CD63 family. CD family: Clonorchis sinensis (GAA49954.1), Schistosoma
mansoni (XP_002580456.1), S. japonicum (CAX70118.1), Danio rerio (NP_001003735.1), Bos taurus (NP_776325.1), Mus musculus (NP_031683.1), Homo
sapiens (NP_004347.1). CD63 family: C. sinensis (GAA50199.1), S. mansoni (AAN17276.1), S. japonicum (CAX70616.1), D. rerio (NP_955837.1), B. taurus
(NP_991372.1), M. musculus (NP_031679.1), H. sapiens (NP_001771.1). Note that the mouse, bovine and human proteins presented on the CD clade
are distinct proteins from those shown in the CD63 clade.
doi:10.1371/journal.pntd.0001939.g002
Figure 3. Expression of Ov-tsp-1 in different developmental
stages of O. viverrini. RNA levels relative to the gene encoding actin,
Ov-actin, were analyzed by real-time qRT-PCR. Transcript levels were
calculated from duplicate specimens from each treatment group and
the data are presented as means 6 SD.
doi:10.1371/journal.pntd.0001939.g003
Figure 4. Immunohistochemical detection of Ov-TSP-1 in tissue
sections of adult O. viverrini in the bile ducts of an infected
hamster. (A–B) Mouse anti-Ov-TSP-1 IgG bound to the tegument (T)
and parasite eggs (E). (C–D) Control serum from the same mouse prior
to immunization did not bind to the same structures. Scale bars are
shown.
doi:10.1371/journal.pntd.0001939.g004
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Discussion
Tetraspanins (TSPs) are a family of membrane-spanning
proteins that display four hydrophobic transmembrane domains
interspersed with two extracellular loops and short intracellular
amino and carboxyl tails [41,42,43]. TSPs are found in all
multicellular eukaryotes where they orchestrate the tetraspanin
web, an association of different transmembrane proteins (including
other TSPs) to stabilize cell membranes and coordinate intracel-
lular and intercellular processes such as signal transduction, cell
proliferation, adhesion, migration, fusion and even host-pathogen
interactions [44,45,46]. Although they have broad functional
importance, defined roles for most mammalian TSPs remain
elusive. Many recent studies have therefore focused on structure
and/or functional relationships of TSPs from vertebrates. Herein
we describe Ov-TSP-1, the first tetraspanin from the carcinogenic
liver fluke, O. viverrini, and provide the first functional analysis
utilizing gene silencing approaches for a TSP from any liver fluke.
Ov-TSP-1 showed the typical TSP structure including the
signature CCG motif, which is the main point for the formation of
two to four disulfide bridges with additional cysteine residues at
fixed positions within the LEL. Members of the TSP family
normally have four to six conserved extracellular cysteines forming
two to three disulfide bonds [45,47,48]. Ov-TSP-1 consists of six
cysteines linked into three putative disulfide bonds. The four
cysteine motifs are greatly derived in the metazoan tetraspanins
and more importantly, that the reduction of cysteines in
tetraspanins has been a recurring trend in the evolution of
tetraspanins [49]. Several TSPs from trematodes have been
discovered in the tegumental membranes, including S. mansoni
TSP-1 and TSP-2 [15], Sm07392 [16,50] and Sm23 [51]. More
recently a TSP was identified using proteomics from the surface of
the liver fluke Fasciola hepatica [52].
Immunolocalization revealed that Ov-TSP-1 is distributed
throughout the membranes of the tegument of adult worms and
eggs in the uterus. Ov-TSP-1 is recognized by sera from O. viverrini-
infected humans and hamsters, indicating that the LEL is
accessible to antibodies and is indeed immunogenic during natural
infection. Moreover, Ov-tsp-1 mRNA is expressed throughout the
life cycle of O. viverrini, implying that the TSP-1 protein is
expressed by the different intra-mammalian developmental stages
and would therefore be continuously presented to the immune
system from excystation of metacercariae to maturation of adult
worms. S. mansoni expresses a family of more than 20 TSPs that
display diverse expression profiles throughout the schistosome’s
development [18]. Indeed one of these, Sm-tsp-3, is accessible on
the surface of live adult S. mansoni [16] and is the most highly
upregulated mRNA in maturing schistosomula [19].
Many TSPs execute their functions through interactions with
integrins. These interactions are important for integrin-mediated
cell adhesion to the extracellular matrix. In addition, tetraspanins
can play roles in intracellular transport, signal transduction, cell
proliferation, adhesion, migration and fusion [46]. As such, they
have been implicated in diverse pathologic processes such as
inflammation, lymphocyte activation and cancer [43]. It is
noteworthy that some mammalian immune cell surface TSPs act
as receptors for pathogens. CD81 is required for internalization of
bacteria such as Listeria monocytogenes [53]. CD81 also acts as a
receptor for hepatitis C virus, and neutralizing anti-HCV
antibodies inhibit virus binding to the LEL of CD81 [54].
TSPs are well represented in invertebrate genomes but to date
little is known about their function. The free-living nematode,
Caenorhabditis elegans, expresses a TSP in its outer surface, the
cuticle, where it plays a critical role in maintenance of epithelial
cell integrity. Silencing of the gene is lethal during molting [55].
To date, only one study has addressed the function of a TSP from
a parasitic helminth from any phylum; Tran and co-workers
demonstrated that silencing of the Sm-tsp-2 gene by RNAi in both
larval and adult intra-mammalian stages of S. mansoni resulted in a
significantly thinner and distinctly vacuolated tegument and
morphology consistent with a failure of tegumentary invaginations
to close [17].
To determine whether O. viverrini TSPs might perform essential
roles in the formation and stability of the tegument of liver flukes,
we used RNAi to silence the expression of Ov-tsp-1 in the adult
stage of the parasite. RNAi has been successfully utilized to silence
gene expression in liver flukes. McGonigle et al. [56] used RNAi to
silence cathepsin B and L gene expression in newly excysted
Figure 5. Western blot analysis for recognition of Ov-TSP-1 by
sera from O. viverrini infected humans and hamsters. Lanes 1,
immunoblot of rOv-TSP-1 probed with serum of O. viverrini infected
human; lane 2, immunoblot of rOv-TSP-1 probed with serum of O.
viverrini infected hamster; lane 3, immunoblot of rOv-TSP-1 probed with
normal serum of hamster and lane 4, immunoblot of rOv-TSP-1 probed
with sera of mice immunized with rOv-TSP-1.
doi:10.1371/journal.pntd.0001939.g005
Figure 6. Suppression of Ov-tsp-1 mRNA in adult O. viverrini by
RNA interference (RNAi). Real time qRT-PCR analysis of Ov-tsp-1
transcription levels relative to Ov-actin (mean6 standard error) showing
reduction in expression of Ov-tsp-1 mRNA in adult O. viverrini on days
(D) 1–16 of ds-Ov-tsp-1 treatment by electroporation and soaking.
Transcript levels were calculated in triplicate from three randomly-
selected parasites from each treatment group and the data are
presented as means 6 SD. Student’s t-tests confirmed significant
differences as indicated.
doi:10.1371/journal.pntd.0001939.g006
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juveniles (NEJs) of F. hepatica and showed a corresponding
reduction in target transcript levels and reduction in the encoded
proteins in the gut. RNAi of either enzyme in NEJs induced
transient, abnormal locomotion phenotypes, and significantly
reduced penetration of the rat intestinal wall. We recently showed
that Cy3-labeled small RNAs could be introduced into adult O.
viverrini by square wave electroporation, and subsequently identi-
fied the RNAs in the parenchyma, gut and reproductive organs
[31]. We electroporated dsRNA targeting the protease cathepsin B
into adult flukes which resulted in a significant reduction in specific
mRNA levels and cathepsin B enzymatic activity [31]. Here we
show that expression of Ov-tsp-1 mRNA was suppressed in adult
flukes by square wave electroporation-mediated RNAi and we
identified a tegument malformation phenotype for the first time for
any liver fluke. RNAi targeting Ov-tsp-1 resulted in deformities of
the tegument of adult worms within 24 hours of exposure to the
dsRNA. These findings indicated a role for Ov-TSP-1 in biogenesis
of the tegumental cell membrane and maintenance of structural
integrity and, when combined with its recognition by antibodies
from infected mammalian hosts, justify further exploration of this
antigen as a target for the development of new therapeutics against
opisthorchiasis.
Tetraspanins from other platyhelminths, including schistosomes
and tapeworms, display protective efficacy when deployed in
recombinant form as experimental vaccines [15,26,27,57,58,59].
More specifically, not only is the schistosome tetraspanin Sm-TSP-
2 selectively recognized by IgG1 and IgG3 antibodies of persons
naturally resistant to S. mansoni infection, recombinant TSPs of S.
mansoni elicit significant protection against challenge infection in
mice [15]. Second, investigation of the extracellular loop of the
tetraspanin T24 of Taenia solium revealed that it provided, in
Western blot analysis, marked sensitivity (94%) and specificity
Figure 7. Ultrastructure of the tegument of adult O. viverrini treated with Ov-tsp-1 dsRNA RNA observed using transmission electron
microscopy. Panel A = Tegument of non-treated adult O. viverrini in RPMI medium for 1 day. Panel B = Tegument of adult O. viverrini treated with
firefly luciferase dsRNA for 1days. Panel C = Tegument of adult O. viverrini treated with Ov-tsp-1 dsRNA for 1days. Panel D= Tegument of non-treated
adult O. viverrini in RPMI medium for 3 days. Panel E and F= Tegument of adult O. viverrini treated with Ov-tsp-1 dsRNA for 3 days. The tegument of
knocked down tsp-1 worm is more highly vacuolated (indicated by arrows) and thinner compared with controls.
doi:10.1371/journal.pntd.0001939.g007
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(98%) in detecting cases of human cysticercosis with two or more
viable cysts [59]. Based on these findings with these platyhelminth
parasite orthologues and the present findings, Ov-TSP-1 can now
be considered as a target at which to develop and target a subunit
vaccine against human opisthorchiasis and associated cholangio-
carcinoma. In addition, given that Ov-TSP-1 is recognized by sera
of infected humans and hamsters, its utility as a serodiagnostic
warrants further investigation. Finally, localization at the surface of
a fluke that resides in the mammalian biliary tree, bathed in bile,
indicates that analysis of interactions of Ov-TSP-1 with its adjacent
receptors, signaling proteins and/or structural components of the
parasite’s tegument will lead to deeper understanding not only of
the anatomic and developmental biology of this carcinogenic fluke
but also of adaptions to parasitism in an ostensibly inimical niche.
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